These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 12418292)

  • 21. Falsely high sirolimus concentrations due to everolimus cross-reactivity in the Siemens sirolimus immunoassay: Corrective actions implemented.
    Bowen R; Rieta R; Joshi R; Lee RC
    Clin Chim Acta; 2019 Feb; 489():162-163. PubMed ID: 29080689
    [No Abstract]   [Full Text] [Related]  

  • 22. When is elevated testosterone not testosterone? When it is an immunoassay interfering antibody.
    Ramaeker D; Brannian J; Egland K; McCaul K; Hansen K
    Fertil Steril; 2008 Sep; 90(3):886-8. PubMed ID: 17953956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carryover: More than just a major hangover for the clinical laboratory.
    Kavsak PA; Zeidler J
    Clin Biochem; 2016 Jul; 49(10-11):735-6. PubMed ID: 27220058
    [No Abstract]   [Full Text] [Related]  

  • 24. Sample to sample carryover: a source of analytical laboratory error and its relevance to integrated clinical chemistry/immunoassay systems.
    Armbruster DA; Alexander DB
    Clin Chim Acta; 2006 Nov; 373(1-2):37-43. PubMed ID: 16777083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of biotin interference on the results of blood hormone assays.
    Ostrowska M; Bartoszewicz Z; Bednarczuk T; Walczak K; Zgliczyński W; Glinicki P
    Endokrynol Pol; 2019; 70(1):102-121. PubMed ID: 30855699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. False positive carbohydrate antigen 19-9 (CA19-9) results due to a low-molecular weight interference in an apparently healthy male.
    Monaghan PJ; Leonard MB; Neithercut WD; Raraty MG; Sodi R
    Clin Chim Acta; 2009 Aug; 406(1-2):41-4. PubMed ID: 19463797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoassay interference: a relatively rare but still important problem.
    Diamandis EP
    Clin Biochem; 2004 May; 37(5):331-2. PubMed ID: 15087246
    [No Abstract]   [Full Text] [Related]  

  • 28. Troponin revisited 2008: assay performance.
    Tate JR
    Clin Chem Lab Med; 2008; 46(11):1489-500. PubMed ID: 18842109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results.
    Hermida J; Tutor JC
    Ther Drug Monit; 2009 Apr; 31(2):269-72. PubMed ID: 19258927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying and reducing potentially wrong immunoassay results even when plausible and "not-unreasonable".
    Ismail AA
    Adv Clin Chem; 2014; 66():241-94. PubMed ID: 25344990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Establishment of revised diagnostic cut-offs for adrenal laboratory investigation using the new Roche Diagnostics Elecsys
    Raverot V; Richet C; Morel Y; Raverot G; Borson-Chazot F
    Ann Endocrinol (Paris); 2016 Oct; 77(5):620-622. PubMed ID: 27449530
    [No Abstract]   [Full Text] [Related]  

  • 32. Interference in immunoassay is an underestimated problem.
    Ismail AA; Walker PL; Cawood ML; Barth JH
    Ann Clin Biochem; 2002 Jul; 39(Pt 4):366-73. PubMed ID: 12117440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interference of circulating endogenous antibodies on the Dimension® DGNA digoxin immunoassay: elimination with a heterophilic blocking reagent.
    Hermida-Cadahía EF; Calvo MM; Tutor JC
    Clin Biochem; 2010 Dec; 43(18):1475-7. PubMed ID: 20875811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eliminating heterophilic antibody interference for ferritin detection using Olympus F(ab')2 based reagent.
    Grouzmann E; Dayer N; Bain C; Neville CM; McCusker MD; Wang RY
    Clin Lab; 2008; 54(9-10):355-7. PubMed ID: 19097493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. False elevation of serum CA-125 level caused by human anti-mouse antibodies.
    Bertholf RL; Johannsen L; Guy B
    Ann Clin Lab Sci; 2002; 32(4):414-8. PubMed ID: 12458896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective Approach to Evaluate Interferences in Immunoassay.
    Warade J
    EJIFCC; 2017 Oct; 28(3):224-232. PubMed ID: 29075172
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heterophilic antibody interference in immunometric assays.
    Bolstad N; Warren DJ; Nustad K
    Best Pract Res Clin Endocrinol Metab; 2013 Oct; 27(5):647-61. PubMed ID: 24094636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnostic variability versus diagnostic errors in cytology].
    Dalla Palma P
    Pathologica; 2001 Oct; 93(5):593-5. PubMed ID: 11725366
    [No Abstract]   [Full Text] [Related]  

  • 39. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature.
    Berth M; Delanghe J
    Acta Clin Belg; 2004; 59(5):263-73. PubMed ID: 15641396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interferences in hormone immunoassays.
    Klee GG
    Clin Lab Med; 2004 Mar; 24(1):1-18. PubMed ID: 15157554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.